Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.

News

December 10, 2008
Merck Introduces New Strategy: BioVentures

December 10, 2008
Merck to Establish a Division Focused on Follow-On Biologics

December 9, 2008
Merck launches unit to sell Biotech Drugs

December 9, 2008
Merck bets on generic biotech in strategic shift

May 9, 2006
Merck & Co., Inc. to Acquire GlycoFi, Inc.
 
January 23, 2006
GlycoFi announces the first production of antibodies with human glycosylation in yeast 

December 12, 2005
GlycoFi and Merck & Co., Inc. enter into Broad Strategic Alliance for Research and Development -- Multi-Year Collaboration to Develop Merck Products on GlycoFi Platform 

 

 

 

 

 


 

SITE MAPPRIVACY POLICYTERMS OF USECOPYRIGHT © 2008-2010 MERCK SHARP & DOHME CORP.,A SUBSIDIARY OF MERCK & CO., INC., WHITEHOUSE STATION, N.J., U.S.A.